AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

140.700

+1.3100.94%

Volume:417.86K

Turnover:58.70M

Market Cap:68.26B

PE:34.37

High:141.260

Open:140.770

Low:139.180

Close:139.390

52wk High:269.118

52wk Low:133.350

Shares:485.15M

Float Shares:483.95M

Volume Ratio:0.39

T/O Rate:0.09%

Dividend:4.18

Dividend Rate:2.97%

EPS(TTM):4.094

EPS(LYR):8.838

ROE:6.66%

ROA:6.58%

PB:2.55

PE(LYR):15.92

Loading ...

Overview Company News Filings

CSL to invest USD 1.5 billion to expand Kankakee, Illinois plasma therapy plant

BRIEF-CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing Facility

CSL: Expansion Will Create at Least 300 New Pharmaceutical Roles

THOMSON REUTERS

CitiFirst CSL SFIs Dividend Estimated Amount-CTW

CSL Seqirus Wins Canada Pandemic Flu Vaccine Contract

Australia stocks lose $93 bln in a week as Mideast war weighs after wild earnings season

CSL - Seqirus Will Provide Adjuvanted Cell-Based Vaccines to Support Canada IF Influenza Pandemic Is Declared by the World Health Organization

THOMSON REUTERS

CSL - CSL Seqirus Awarded New Contract to Support Influenza Pandemic Preparedness Plans of Canadian Government’s Public Health Agency of Canada

THOMSON REUTERS

Market Chatter: CSL Secures Canada Pandemic Influenza Vaccine Supply Contract, AFR Says

MT Newswires Live

Skillful Craftsman Unit Signs 12-Month CSL AI Service Deal With China Auto Insurance Firm

Arcturus Therapeutics Q4 net loss narrows

Pfisterer posts FY 2025 order backlog of EUR 335 million, up more than 40%

Organic Growth in Australia's Healthcare Services Likely Due to Increased Availability of Bulk-Billing General Practitioners, Jefferies Says

MT Newswires Live

A Look At CSL (ASX:CSL) Valuation After Clazakizumab Deal And Recent Earnings Pressure

Simply Wall St.

CSL Vacuum Science and Technology Posts 19% Slide in 2025 Profit, Revenue Down 2%

MT Newswires Live

Did Soft Half-Year Results and CEO Transition Just Shift CSL's (ASX:CSL) Investment Narrative?

Simply Wall St.

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

CORRECTED-Australian shares dip on U.S. tariff jitters; miners buck the trend

Australian stocks fall as US tariff move sours risk appetite

CSL Ltd-Change of Director's Interest Notice

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":140.7,"timestamp":1774405832768,"preClose":139.39,"halted":0,"volume":417862,"delay":0,"changeRate":0.009398091685199816,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":485151394,"eps":4.0935868017658,"marketStatus":"Trading","change":1.31,"latestTime":"03-25 13:30:35 AEDT","open":140.77,"high":141.26,"low":139.18,"amount":58699641,"amplitude":0.014922,"askPrice":140.72,"askSize":98,"bidPrice":140.7,"bidSize":87,"shortable":3,"etf":0,"ttmEps":4.0935868017658,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774414800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":139.39,"dividendRate":0.029446,"openAndCloseTimeList":[[1774393200000,1774414800000]],"volumeRatio":0.389513,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":139.39,"auctionPrice":140.7,"auctionVolume":16016,"auctionTime":1774393143928,"referenceTime":1774344603091,"auction":1,"marketStatus":"盘前竞价","timestamp":1774393143928}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.58%","roe":"6.66%","lyrEps":8.83759,"volumeRatio":0.389513,"shares":485151394,"dividePrice":4.182458,"high":141.26,"amplitude":0.014922,"preClose":139.39,"low":139.18,"week52Low":133.35,"pbRate":"2.55","psRate":"3.09","week52High":269.118,"institutionHeld":0,"latestPrice":140.7,"committee":-0.059459,"eps":4.0935868017658,"divideRate":0.029726,"volume":417862,"delay":0,"ttmEps":4.0935868017658,"open":140.77,"prevYearClose":170.408,"prevWeekClose":138.5,"prevMonthClose":144.854,"prevQuarterClose":170.408,"fiveDayClose":138,"twentyDayClose":143.225,"sixtyDayClose":171.296,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":4,"dividendGrowthRate":0.11620984529927163,"fiveYearAvgDividendRate":0.013228653048611719},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"},{"date":"2025-08-19","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755561600000,"name":null,"time":"","dateTimestamp":1755525600000,"actualEps":null},{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618627430","title":"CSL to invest USD 1.5 billion to expand Kankakee, Illinois plasma therapy plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627430","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618627430?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:01","pubTimestamp":1773068486,"startTime":"0","endTime":"0","summary":"CSL broke ground on an expansion of its plasma-therapy manufacturing facility in Kankakee, Illinois. The project includes a USD 1.5 billion investment to increase production of plasma-derived therapies and albumin. CSL said the expansion is expected to be operational by 2031 and will incorporate its Horizon 2 manufacturing process to increase immunoglobulin yield from the same amount of plasma. The company expects the expansion to create at least 300 new pharmaceutical roles and about 800 construction-related jobs. CSL said it has invested more than USD 3 billion in its U.S. operations since 2018.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL6mhmJt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7511","CSL.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2618442627","title":"BRIEF-CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2618442627","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618442627?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:00","pubTimestamp":1773068403,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing FacilityMarch 9  - CSL Ltd CSL.AX:CSL: ANNOUNCES EXPANSION OF ILLINOIS PLASMA THERAPY MANUFACTURING FACILITYCSL: KANKAKEE ILLINOIS FACILITY EXPANSION, EXPECTED TO BE OPERATIONAL BY 2031CSL: EXPANSION WILL CREATE AT LEAST 300 NEW PHARMACEUTICAL ROLESFurther company coverage: CSL.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nP8N3T600Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7508","CSL.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2618627621","title":"CSL: Expansion Will Create at Least 300 New Pharmaceutical Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618627621?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:00","pubTimestamp":1773068400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nP8N3T600Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2618615680","title":"CitiFirst CSL SFIs Dividend Estimated Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2618615680","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618615680?lang=en_us&edition=fundamental","pubTime":"2026-03-09 10:26","pubTimestamp":1773023202,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260309:nASX169Mry","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nASX7w6wtP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2617632533","title":"CSL Seqirus Wins Canada Pandemic Flu Vaccine Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617632533?lang=en_us&edition=fundamental","pubTime":"2026-03-07 01:59","pubTimestamp":1772819991,"startTime":"0","endTime":"0","summary":"CSL Limited unit CSL Seqirus won a new contract with Canada’s Public Health Agency of Canada to support the country’s influenza pandemic preparedness plans. Under the agreement, CSL Seqirus will rapidly manufacture and deliver millions of doses of cell-based adjuvanted influenza vaccines if the World Health Organization declares an influenza pandemic, shifting from a prior egg-based vaccine arrangement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL3lQ6s7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CSL.AU","BK4590","FUN","BK4216","BK7511","BK7508","BK7501"],"gpt_icon":0},{"id":"2617506716","title":"Australia stocks lose $93 bln in a week as Mideast war weighs after wild earnings season","url":"https://stock-news.laohu8.com/highlight/detail?id=2617506716","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617506716?lang=en_us&edition=fundamental","pubTime":"2026-03-06 11:07","pubTimestamp":1772766466,"startTime":"0","endTime":"0","summary":"Australia stocks lose $93 bln in a week as Mideast war weighs after wild earnings seasonASX 200 fell 3.8% this week, undoing half of February's gainsAnalysts warn of more stock losses if conflict prolongedEarnings season saw record share swings, JPMorgan saysBy Sneha  Kumar and Shivangi  Lahiri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nL4N3ZR05R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAB.AU","BK7511","BK7040","BK7095","BK7135","BK7507","ANZ.AU","WOW.AU","BHP.AU","BK7067","CBA.AU","WBC.AU","BK7501","BK7508","CSL.AU"],"gpt_icon":0},{"id":"2617648547","title":"CSL - Seqirus Will Provide Adjuvanted Cell-Based Vaccines to Support Canada IF Influenza Pandemic Is Declared by the World Health Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2617648547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617648547?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:01","pubTimestamp":1772715701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0SK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7511","BK7508","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2617547577","title":"CSL - CSL Seqirus Awarded New Contract to Support Influenza Pandemic Preparedness Plans of Canadian Government’s Public Health Agency of Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2617547577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617547577?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:01","pubTimestamp":1772715701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2617811596","title":"Market Chatter: CSL Secures Canada Pandemic Influenza Vaccine Supply Contract, AFR Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2617811596","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617811596?lang=en_us&edition=fundamental","pubTime":"2026-03-05 10:26","pubTimestamp":1772677570,"startTime":"0","endTime":"0","summary":"CSL's  influenza vaccine unit, Seqirus, has secured a contract to supply 15 million doses of a cell-based adjuvanted pandemic flu vaccine from its new Melbourne facility if a pandemic is declared by the World Health Organization, according to a Thursday report by the Australian Financial Review.CSL Seqirus has previously had a contract with Canada, under which it was required to provide an egg-based influenza vaccine in the event of a pandemic, the report added.The company's shares rose almost 2% in recent Thursday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169589451.USD","BK7501","BK7511","SGXZ23171101.USD","SG9999004303.SGD","BK7508","BK7067","CSL","LU0728928796.USD","LU1169590202.USD","BK4086","CSL.AU"],"gpt_icon":0},{"id":"2616553266","title":"Skillful Craftsman Unit Signs 12-Month CSL AI Service Deal With China Auto Insurance Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553266","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616553266?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:31","pubTimestamp":1772631080,"startTime":"0","endTime":"0","summary":"Skillful Craftsman Education Technology Ltd. said its wholly owned subsidiary, Shenzhen Qianhai Jisen Information Technology Co., Ltd., signed an AI Technology Service and Product Sales Agreement with an auto insurance service company in China. Under the 12-month contract, Jisen will provide its self-developed Communication Skills Learning  intelligent communication assistance product and related services for employee training, customer service support, and sales script optimization. The agreement runs from Feb. 25, 2026 to Feb. 24, 2027, with monthly fees of RMB 100,000 excluding tax.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6hnCqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","LU2210150020.SGD","SG9999014021.USD","SG9999014039.USD","BK4112","LU0314104364.USD","IE00BKPKM429.USD","BK7511","IE00BGHQF748.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","BK7508","IE00B64PRP62.GBP","LU2095319765.USD","BK4588","BK4204","EDTK","SG9999014005.SGD","NDAQ","CSL.AU","BK4585","LU2210149790.SGD"],"gpt_icon":0},{"id":"2616737103","title":"Arcturus Therapeutics Q4 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2616737103","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616737103?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:09","pubTimestamp":1772572187,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Q4 net loss narrowsOverviewmRNA medicines firm's Q4 revenue fell due to reduced CSL collaboration activityOperating expenses for Q4 decreased, driven by lower manufacturing and c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL1N3ZR192:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7508","BK4139","BK7501","ARCT","BK7067"],"gpt_icon":0},{"id":"2616316503","title":"Pfisterer posts FY 2025 order backlog of EUR 335 million, up more than 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616316503","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616316503?lang=en_us&edition=fundamental","pubTime":"2026-03-03 15:01","pubTimestamp":1772521268,"startTime":"0","endTime":"0","summary":"PFISTERER posted preliminary unaudited FY 2025 results showing sales of about EUR 450 million  and adjusted EBITDA of about EUR 80 million . Order intake rose to just under EUR 550 million , lifting the order backlog to nearly EUR 335 million  as of Dec. 31, 2025. Adjusted operating cash flow increased to about EUR 58 million , while investments rose to more than EUR 38 million, primarily to expand capacities, build an HVDC laboratory and complete the acquisition of Power CSL. Q4 2025 sales were about EUR 120 million . The company said final audited FY 2025 figures and a 2026 outlook are due on April 15, 2026, and reiterated its strategic focus on capacity expansion, global presence and HVDC-related innovation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL5QCLn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","CSL.AU","BK7511","BK7508","BK7067"],"gpt_icon":0},{"id":"2616804550","title":"Organic Growth in Australia's Healthcare Services Likely Due to Increased Availability of Bulk-Billing General Practitioners, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2616804550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616804550?lang=en_us&edition=fundamental","pubTime":"2026-03-02 12:27","pubTimestamp":1772425659,"startTime":"0","endTime":"0","summary":"An organic growth in Australian healthcare services is likely due to improving availability of bulk-billing general practitioners, offset by ongoing wage pressures, Jefferies said in a Monday report.I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IDX.AU","BK7089","CUV.AU","REG.AU","XBI","MSB.AU","BK7067","BK4588","HLS.AU","XLV","BK4585","BK7124","LABU","XJO.AU","ANN.AU","BK7126","NEU.AU","COH.AU","BK7501","NHF.AU","BK7508","CU6.AU","IMM.AU","BK7096","RHC.AU","XKO.AU","BK7103","CSL.AU","BK7511","TLX.AU","MVF.AU","MPL.AU","BK7007","FPH.AU","BK7113","SIG.AU","XAO.AU","HCAR","SHL.AU","BK4581","BK7509"],"gpt_icon":0},{"id":"2614997880","title":"A Look At CSL (ASX:CSL) Valuation After Clazakizumab Deal And Recent Earnings Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2614997880","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614997880?lang=en_us&edition=fundamental","pubTime":"2026-02-27 15:42","pubTimestamp":1772178161,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) has come into focus after out licensing its IL 6 antibody clazakizumab to Eli Lilly, securing A$100 million up front, along with future milestones and royalties tied to Lilly led development.\nSee our latest analysis for CSL.\nThat clazakizumab deal lands at a time when CSL’s share price has been under pressure, with a 30 day share price return showing an 18.55% decline, a 90 day share price return showing a 21.22% decline and a 1 year total shareholder return showing a 42.56%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-look-at-csl-asxcsl-valuation-after-clazakizumab-deal-and-r","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-look-at-csl-asxcsl-valuation-after-clazakizumab-deal-and-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL","CSL.AU"],"gpt_icon":0},{"id":"2614264886","title":"CSL Vacuum Science and Technology Posts 19% Slide in 2025 Profit, Revenue Down 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614264886","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614264886?lang=en_us&edition=fundamental","pubTime":"2026-02-27 14:28","pubTimestamp":1772173718,"startTime":"0","endTime":"0","summary":"Shenzhen CSL Vacuum Science and Technology  posted 2025 attributable net profit of 114.4 million yuan, down 19% from 141.5 million yuan the previous year.Basic earnings per share declined to 2.25 yuan from 2.79 yuan, according to a Friday filing with the Shanghai bourse.Operating revenue slid 2.0% year over year to 530.3 million yuan from 540.8 million yuan.Shares of the semiconductor equipment components manufacturer were down 1% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","CSL"],"gpt_icon":0},{"id":"2614405399","title":"Did Soft Half-Year Results and CEO Transition Just Shift CSL's (ASX:CSL) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614405399","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614405399?lang=en_us&edition=fundamental","pubTime":"2026-02-26 01:59","pubTimestamp":1772042374,"startTime":"0","endTime":"0","summary":"CSL’s half-year results and ongoing CEO transition, reported prior to today, disappointed parts of the market and raised questions about the company’s near-term execution and leadership stability.\nAt the same time, smaller rival Telix Pharmaceuticals drew attention with very large revenue growth and progress on a differentiated brain cancer imaging agent in Europe, sharpening comparisons within the biopharma sector.\nWe’ll now examine how concerns around CSL’s CEO transition may influence the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-soft-half-year-results-and-ceo-transition-just-shift-csl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-soft-half-year-results-and-ceo-transition-just-shift-csl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SGXZ23171101.USD","CSL","BK7501","CSL.AU","LU1169589451.USD","SG9999004303.SGD","BK4086","BK7067","LU0728928796.USD","LU1169590202.USD","BK7508","BK7511"],"gpt_icon":0},{"id":"2613736365","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2613736365","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613736365?lang=en_us&edition=fundamental","pubTime":"2026-02-24 01:09","pubTimestamp":1771866559,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsUpdates Lilly, J&J, AbbVie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL4N3ZJ18E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134523.USD","LU1814569148.SGD","LU2237443622.USD","LU0553294199.USD","LU0683600562.USD","LU1267930573.SGD","JNJ","LU0575583348.USD","SGXZ99366536.SGD","SG9999014575.USD","BK4007","LU2237438978.USD","LU0096364046.USD","LLYZ","LU2089283258.USD","LU1699723380.USD","BK4559","BK7067","IE0004445239.USD","03165","LU1066053197.SGD","LU0456855351.SGD","LU1032955483.USD","LU1066051225.USD","LU0170899867.USD","LU1066051498.USD","LU2896262040.SGD","IE00B7SZLL34.SGD","ELIS","LU0122379950.USD","LU0976567544.SGD","LU1261432733.SGD","IE00BZ1G4Q59.USD","LU2491050071.SGD","LU2361044865.SGD","LU1989772923.USD","BIIB","LU1064927863.SGD","BK7511","LU0321505439.SGD","SG9999002232.USD","IE0034235188.USD","LU0210536198.USD","LU0345777659.USD","IE00BFSS8Q28.SGD","LU1894683348.USD","LU0130102774.USD","LU2293690082.USD","LU2357305700.SGD","LU2237443978.SGD","LU0234570918.USD","IE00BJJMRX11.SGD","LU0109394709.USD","LU0920783379.SGD","SG9999014559.SGD","LU0889566641.SGD","LU2417539215.USD","BK4588","LU0545039389.USD","LU2114397693.USD","IE00BGHQF631.EUR","LU1548497426.USD","LU0070302665.USD","LU0203201768.USD","LU1232071149.USD","LU2271345857.HKD","LU1506573853.SGD","LU0306807586.USD","LU1934455277.USD","LU1934455863.HKD","LU0234572021.USD","LU2491050154.USD","LU0557290698.USD","IE00B4R5TH58.HKD","LU0980610538.SGD","LU1989771016.USD","LU0787776722.HKD","LU1674673691.USD","LU2168563687.JPY","IE00BN29S564.USD","LU1868837300.USD","IE00BJLML261.HKD","IE00BLSP4239.USD","LU1868836914.USD","LU1291159041.SGD","IE00BKPKM643.USD","SG9999014880.SGD","LU0323591593.USD","LU2028103732.USD","LU2746668461.USD","LU2471134879.HKD","LU0920840948.USD","SGXZ51526630.SGD","LU0211326839.USD","LU0471298694.HKD","LU0857590862.USD","LU2125154778.USD","LU0882574139.USD","LU1804176565.USD","LU0203202063.USD","LU1732800096.USD","IE00BKVL7J92.USD","LU0640478417.SGD","BK4504","LU0203345920.USD","LU2430703095.HKD","LU1718418525.SGD","BK4532","LU1629891620.HKD","LU0310799852.SGD","LU1170363599.USD","LU2746668974.SGD","IE00B894F039.SGD","LU0094547139.USD","LU2471134796.USD","IE0004445015.USD","BK4578","LU0784385170.HKD","LU0354030438.USD","LU2237443895.HKD","LU2360106947.USD","LU2111349929.HKD","LU1069344957.HKD","IE00BJJMRY28.SGD","LU0124676726.USD","LU0526926950.USD","LU1015430645.USD","LU2471134952.CNY","LU1093756168.USD","LU2168564065.EUR","SG9999015945.SGD","LU0289739343.SGD","LU1720051108.HKD","LU1551013342.USD","LU0320765992.SGD","SG9999001176.SGD","LU1894683264.USD","LU1023059063.AUD","SG9999014542.SGD","NVS","BK4566","IE00BFTCPJ56.SGD","LU2023250504.SGD","IE00BFSS7M15.SGD","LU1496350171.SGD","LU0320765059.SGD","04332","LU1032466523.USD","LU1116320737.USD","SG9999015952.SGD","IE00BVYPNV92.GBP","LU0320765489.SGD","BK4568","LU0047473722.SGD","RHHBY","LU1323610961.USD","LU2211815571.USD","IE000M9KFDE8.USD","SG9999017495.SGD","LU0969580561.USD","IE00BK4W5M84.HKD","LU0661504455.SGD","LU2539964713.USD","SG9999013999.USD","LU0784384876.USD","LU0353189763.USD","LU1983299246.USD","LU1551013425.SGD","SG9999014914.USD","SG9999018857.SGD","LU2063271972.USD","LU0471298777.SGD","LU0011850046.USD","LU0957799991.USD","LU0795875086.SGD","LU0077335932.USD","LU0070217475.USD","LU1066051811.HKD","LU1674673428.USD","LU0057025933.USD","LU2237443382.USD","LU1244550494.USD","IE00B3T34201.USD","LU2129689431.USD","LU0225771236.USD","LU0887340254.USD","IE0001KFT4U8.USD","LU0823434740.USD","LU2293690249.USD","LU1496350502.SGD","LU1868836757.USD","SG9999015358.SGD","BK4533","LU0466842654.USD","LU1481599808.USD","LU0211328371.USD","LU1988902786.USD","LU1019632923.USD","LU0823434583.USD","LU0417517546.SGD","SG9999001176.USD","LU1069347547.HKD","LU1778281490.HKD","LU0211326755.USD","IE00B7KXQ091.USD","BK4592","LU0306806265.USD","LU0385154629.USD","LU1127390331.HKD","LU0689626769.HKD","IE00B1BXHZ80.USD","LU2279689827.SGD","LU1104425308.USD","LU1061106388.HKD","LU2461242641.AUD","PFE","LU1267930730.SGD","LU0208291251.USD","LU2750360997.AUD","LU0265550359.USD","LU0128525929.USD","LU0964807845.USD","LU1974910355.USD","LU2430703178.SGD","LU0106261372.USD","LU2491049909.HKD","IE00B3PB1722.GBP","LU0006306889.USD","IE00BJJMRZ35.SGD","LU2430703251.USD","LU2091194634.USD","IE00B42XCP33.USD","CSL.AU","LU0708995401.HKD","LU1244550221.USD","LU1064131342.USD","ELIL","LU0827474353.SGD","GSK","LU0912757837.SGD","LU2552382215.SGD","LU0943347566.SGD","LU0786609619.USD","LU1481600234.SGD","LU1244550577.SGD","LU1037948897.HKD","LU0757432116.USD","LU1196500208.SGD","LU0823399737.USD","LU0648001328.SGD","LU0128525689.USD","LU0795875169.SGD","LU1935042991.SGD","LU0069063385.USD","LU0708994859.HKD","LU0949170426.SGD","LU0211327993.USD","SG9999015978.USD","LU1712237335.SGD","LU0310800965.SGD","IE00BFXG1179.USD","LU1059921491.USD","SGXZ57979304.SGD","LU1280957306.USD","LU0965509010.AUD","LU0029864427.USD","LU0061475181.USD","LU2129689514.USD","LU0321505868.SGD","LU2023250330.USD","LU2552382058.USD","LU0861579265.USD","LU1839511570.USD","LU1003077747.HKD","LU0353189680.USD","BK5011","LU0784383803.USD","LU0171293334.USD","LU2087625088.SGD","LU1057294990.SGD","LU2133065610.SGD","IE00BDGV0183.EUR","LU0097036916.USD","LU0158827948.USD","IE00B19Z3581.USD","BK4516","LU0289961442.SGD","IE00BSNM7G36.USD","LU0963555726.SGD","LU0640476718.USD","LU0345777147.USD","LU0225284248.USD","LU2168564222.USD","LU1430594728.SGD","SG9999014898.SGD","LU0225283273.USD","LU2237443549.SGD","LU0499090636.EUR","LU0784385840.USD","LU1084165304.USD","LU0114720955.EUR","SG9999003800.SGD","LU0985481810.HKD","MRK","LU1989772840.SGD","GB00BDT5M118.USD","LU0058720904.USD","IE00B19Z3B42.SGD","IE00BWXC8680.SGD","LU0203347892.USD","SG9999014567.USD","LLII","LU1301847155.USD","LU0820562030.AUD","LU1914381329.SGD","LU2089984988.USD","LU1267930490.SGD","IE00BBT3K403.USD","LU0964806797.USD","LU0965509283.SGD","LU0432979614.USD","IE00B2B36J28.USD","LU0960981461.USD","LU0792757196.USD","LU1153584641.USD","LU2756315664.SGD","SG9999014906.USD","LU0052756011.USD","LU1941712348.USD","BK4585","LU1145028129.USD","LU1162221912.USD","LU0738911758.USD","LU2023251221.USD","LU1720051017.SGD","LU2265009873.SGD","LU0985320562.USD","LU2108987350.USD","LU1003076772.USD","LU1929549753.HKD","IE0002141913.USD","IE00B19Z9Z06.USD","LU1221951046.USD","LU2361045086.USD","LU0965508806.USD","LU0265550946.USD","LU0345770308.USD","LU1074936037.SGD","LU2756315318.SGD","LU0477156953.USD","LU0345769128.USD","LU1883839398.USD","LU0198837287.USD","LU1917777945.USD","LU2089284900.SGD","LU2361044949.HKD","LU1221951129.SGD","LU2106854487.HKD","ABBV","LU0047473722.EUR","LU2168564495.EUR","LU2213496289.HKD","LU0289739699.SGD","LU1037948541.HKD","LU2505996509.AUD","LU2168564149.EUR","LU1035775433.USD","LU2456880835.USD","SG9999015986.USD","LU0320765646.SGD","IE00BN8TJ469.HKD","LU0130517989.USD","LU1880407215.USD","BK7508","LU0256863902.USD","LU2347655156.SGD","LU2129689605.HKD","LU0472753341.HKD","LU1880407132.USD","GILD","SNY","LU2468319806.SGD","LU2462157665.USD","IE00BLSP4452.SGD","LU1153585028.USD","IE00BKPKM429.USD","BK4550","LU0949170772.SGD","LU2237443465.HKD","LU0511384066.AUD","LU0868494617.USD","LU2264538146.SGD","LU2112291526.USD","LU0672654240.SGD","AZN","IE00BK4W5L77.USD","LU1119994496.HKD","LU0820561909.HKD","LU1366192091.USD","LU1623119135.USD","IE00B1XK9C88.USD","LU1116320901.HKD","LU1051770623.HKD","LU2505996681.GBP","LU2324357040.USD","LU1487256676.USD","LU2023250843.SGD","IE0002270589.USD","LU1035773651.USD","SGXZ81514606.USD","LU0689472784.USD","LU0889565916.HKD","LU2602419157.SGD","LU1585245621.USD","LU0972486137.USD","BK4583","BK4581","IE0009355771.USD","IE00BJT1NW94.SGD","LU0345769631.USD","IE0034235303.USD","LU0211331839.USD","BK4534","LU0109391861.USD","SGXZ31699556.SGD","LU0316494557.USD","LU2552382132.HKD","LU0354030511.USD","LU2592432038.USD","IE00B775H168.HKD","LU2236285917.USD","IE00BKDWB100.SGD","LU0158827781.USD","LU0310800379.SGD","LU0997586432.USD","LU1868837136.USD","LU0238689110.USD","LU1868836591.USD","LU2087621335.USD","LU0098860793.USD","LU1093756325.SGD","LLYX","LU0256863811.USD","LU1941712264.USD","LU2242652126.USD","SG9999018865.SGD","LU1571399168.USD","LU1078025761.USD","LU0965509101.SGD","LU0882574055.USD","IE00B19Z9P08.USD","LU2360032135.SGD","IE00BVYPNW00.USD","LU1732799900.SGD","LU1934455194.USD","LU1201861249.SGD","IE0005OL40V9.USD","BK7501","AMGN","BK4599","LU0496365809.HKD","LU1267930813.SGD","LU1019634622.SGD","LU1267930227.SGD","LU2242646821.SGD","LU2125154935.USD","LU0820561818.USD","LU2750360641.GBP","LU0345770993.USD","SG9999002224.SGD","LU0889565080.SGD","BK4139","SG9999011175.SGD","LU0079474960.USD","LU0266013472.USD","SG9999001440.SGD","LU0823416689.USD","SG9999015341.SGD","IE00B4JS1V06.HKD","LLY"],"gpt_icon":1},{"id":"2613720146","title":"CORRECTED-Australian shares dip on U.S. tariff jitters; miners buck the trend","url":"https://stock-news.laohu8.com/highlight/detail?id=2613720146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613720146?lang=en_us&edition=fundamental","pubTime":"2026-02-23 14:20","pubTimestamp":1771827642,"startTime":"0","endTime":"0","summary":"CORRECTED-Australian shares dip on U.S. tariff jitters; miners buck the trendCorrects paragraph 14 to say New Zealand benchmark rose 0.8%, not fell 0.8%By Shruti  Agarwal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL6N3ZJ05K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7508","BK7507","CSL.AU","BK7095","BHP.AU","BK7511"],"gpt_icon":0},{"id":"2613027081","title":"Australian stocks fall as US tariff move sours risk appetite","url":"https://stock-news.laohu8.com/highlight/detail?id=2613027081","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613027081?lang=en_us&edition=fundamental","pubTime":"2026-02-23 09:17","pubTimestamp":1771809444,"startTime":"0","endTime":"0","summary":"Australian stocks fall as US tariff move sours risk appetite Feb 23 (Reuters) - Australian shares fell on Monday, dragged down by tech, real estate and energy stocks, as investors weighed the impact o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL6N3ZJ00U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","TWE.AU","CSL.AU","BK7095","WDS.AU","BK7097","BK7506","XRO.AU","BK7507","BK7503","BK7065","BK7508","ALD.AU","BK7142","BK7511","BK7104","WTC.AU","BK7505","BHP.AU","BK7016","NST.AU","EVN.AU"],"gpt_icon":0},{"id":"2612947955","title":"CSL Ltd-Change of Director's Interest Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2612947955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612947955?lang=en_us&edition=fundamental","pubTime":"2026-02-19 11:43","pubTimestamp":1771472595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUE4LM7YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7508","BK7067","BK7511"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":198,"code":"91000000","status":"200"}]}}